HUP9902458A2 - Nyújtott hatóanyag-leadású, mizolasztintartalmú gyógyszerkészítmények - Google Patents

Nyújtott hatóanyag-leadású, mizolasztintartalmú gyógyszerkészítmények

Info

Publication number
HUP9902458A2
HUP9902458A2 HU9902458A HUP9902458A HUP9902458A2 HU P9902458 A2 HUP9902458 A2 HU P9902458A2 HU 9902458 A HU9902458 A HU 9902458A HU P9902458 A HUP9902458 A HU P9902458A HU P9902458 A2 HUP9902458 A2 HU P9902458A2
Authority
HU
Hungary
Prior art keywords
mizolastin
slow
release pharmaceutical
pharmaceutical formulations
formulations containing
Prior art date
Application number
HU9902458A
Other languages
English (en)
Inventor
Maryvonne Chariot
Gareth Lewis
Jean Montel
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of HUP9902458A2 publication Critical patent/HUP9902458A2/hu
Publication of HUP9902458A3 publication Critical patent/HUP9902458A3/hu
Publication of HU227472B1 publication Critical patent/HU227472B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pulmonology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

A találmány tárgya mizőlasztint tartalmazó, nyújtőtt hatóanyag-leadásúgyógyszerészeti készítmény, amely tartalmaz egy magőt, amely egy amizőlasztint, egy zsír-mátrixőt és egy szerves savat tartalmazó,nyújtőtt hatóanyag-leadású tablettából áll, amely tablettabevőnattalvan ellátva. ŕ
HU9902458A 1996-03-04 1997-02-28 Slow-release pharmaceutical formulations containing mizolastin HU227472B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9602662A FR2745500B1 (fr) 1996-03-04 1996-03-04 Formulations pharmaceutiques a liberation prolongee contenant de la mizolastine
PCT/FR1997/000355 WO1997032584A1 (fr) 1996-03-04 1997-02-28 Formulations pharmaceutiques a liberation prolongee contenant de la mizolastine

Publications (3)

Publication Number Publication Date
HUP9902458A2 true HUP9902458A2 (hu) 2000-05-28
HUP9902458A3 HUP9902458A3 (en) 2002-11-28
HU227472B1 HU227472B1 (en) 2011-07-28

Family

ID=9489799

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9902458A HU227472B1 (en) 1996-03-04 1997-02-28 Slow-release pharmaceutical formulations containing mizolastin

Country Status (35)

Country Link
US (2) US6165507A (hu)
EP (1) EP0906101B1 (hu)
JP (2) JP2000512617A (hu)
KR (1) KR100369888B1 (hu)
CN (1) CN1112929C (hu)
AR (1) AR006082A1 (hu)
AT (1) ATE219365T1 (hu)
AU (1) AU725494B2 (hu)
BG (1) BG63451B1 (hu)
BR (1) BR9707827A (hu)
CA (1) CA2247405C (hu)
CO (1) CO4780020A1 (hu)
CY (1) CY2293B1 (hu)
CZ (1) CZ291418B6 (hu)
DE (1) DE69713505T2 (hu)
DK (1) DK0906101T3 (hu)
EE (1) EE03511B1 (hu)
ES (1) ES2177942T3 (hu)
FR (1) FR2745500B1 (hu)
HK (1) HK1017999A1 (hu)
HU (1) HU227472B1 (hu)
IL (1) IL126050A (hu)
IN (1) IN187739B (hu)
NO (1) NO315841B1 (hu)
NZ (1) NZ331947A (hu)
OA (1) OA10854A (hu)
PL (1) PL189813B1 (hu)
PT (1) PT906101E (hu)
RU (1) RU2173997C2 (hu)
SK (1) SK282112B6 (hu)
TR (1) TR199801574T2 (hu)
TW (1) TW491711B (hu)
UA (1) UA49004C2 (hu)
WO (1) WO1997032584A1 (hu)
ZA (1) ZA971830B (hu)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002087960A (ja) * 2000-07-14 2002-03-27 Toyama Chem Co Ltd 徐放性錠剤
ES2392705T3 (es) * 2000-10-02 2012-12-13 Usv Ltd. Composiciones farmacéuticas de liberación sostenida que contienen metformina y método para su producción
US7052706B2 (en) 2001-06-08 2006-05-30 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
US20030181488A1 (en) * 2002-03-07 2003-09-25 Boehringer Ingelheim Pharma Gmbh & Co. Kg Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
WO2004078164A1 (en) * 2003-03-04 2004-09-16 Nostrum Pharmaceuticals, Inc. Control release formulation containing a hydrophobic material as the sustained release agent
DE10337697A1 (de) * 2003-08-16 2005-03-24 Boehringer Ingelheim Pharma Gmbh & Co. Kg Tablette enthaltend 3-[(2-{[4-(Hexyloxycarbonylamino-imino-methyl)-phenyl-amino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionsäure-ethylester oder dessen Salze
US9186411B2 (en) * 2008-07-28 2015-11-17 Takeda Pharmaceutical Company Limited Pharmaceutical composition
JP5744412B2 (ja) * 2010-03-26 2015-07-08 テバ製薬株式会社 フロセミド製剤
US20140179712A1 (en) 2012-12-21 2014-06-26 Astrazeneca Ab Pharmaceutical formulation of n-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2h-pyrazol-3-yl]-4-[(3r,5s)-3,5-dimethylpiperazin-1-yl]benzamide

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364945A (en) * 1979-12-13 1982-12-21 Whittle Barry J Nasal composition for relieving nasal distress
US4421736A (en) * 1982-05-20 1983-12-20 Merrel Dow Pharmaceuticals Inc. Sustained release diethylpropion compositions
US4590062A (en) * 1984-04-16 1986-05-20 Tech Trade Corp. Dry direct compression compositions for controlled release dosage forms
FR2587029B1 (fr) * 1985-09-11 1987-10-30 Synthelabo Derives de benzimidazole, leur preparation et leur application en therapeutique
JPH0776172B2 (ja) * 1986-04-16 1995-08-16 藤沢薬品工業株式会社 マトリツクス錠
JPS62283926A (ja) * 1986-06-02 1987-12-09 Nippon Chemiphar Co Ltd 塩酸ニカルジピン持続性組成物
DE3812799A1 (de) * 1988-04-16 1989-10-26 Sanol Arznei Schwarz Gmbh Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung
JP3195391B2 (ja) * 1991-11-14 2001-08-06 エスエス製薬株式会社 徐放性トラピジル錠
US5686105A (en) * 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
IT1264696B1 (it) * 1993-07-09 1996-10-04 Applied Pharma Res Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata
JPH07112932A (ja) * 1993-08-27 1995-05-02 Mitsui Toatsu Chem Inc 徐放性医薬製剤

Also Published As

Publication number Publication date
TR199801574T2 (xx) 1998-11-23
TW491711B (en) 2002-06-21
CN1212624A (zh) 1999-03-31
NO984035L (no) 1998-10-22
CN1112929C (zh) 2003-07-02
US6165507A (en) 2000-12-26
IL126050A (en) 2004-05-12
FR2745500B1 (fr) 1998-04-03
JP2007182451A (ja) 2007-07-19
PT906101E (pt) 2002-09-30
CZ291418B6 (cs) 2003-03-12
EP0906101B1 (fr) 2002-06-19
AU725494B2 (en) 2000-10-12
AR006082A1 (es) 1999-08-11
CA2247405A1 (en) 1997-09-12
DK0906101T3 (da) 2002-10-14
US20050202089A1 (en) 2005-09-15
PL189813B1 (pl) 2005-09-30
WO1997032584A1 (fr) 1997-09-12
UA49004C2 (uk) 2002-09-16
KR19990087387A (ko) 1999-12-27
EE9800275A (et) 1999-02-15
OA10854A (fr) 2003-02-05
ATE219365T1 (de) 2002-07-15
BG63451B1 (bg) 2002-02-28
CY2293B1 (en) 2003-07-04
DE69713505T2 (de) 2003-02-13
BG102692A (en) 1999-04-30
NO315841B1 (no) 2003-11-03
EE03511B1 (et) 2001-10-15
NO984035D0 (no) 1998-09-02
HUP9902458A3 (en) 2002-11-28
CA2247405C (en) 2004-04-20
ES2177942T3 (es) 2002-12-16
HU227472B1 (en) 2011-07-28
AU1930097A (en) 1997-09-22
NZ331947A (en) 2000-03-27
FR2745500A1 (fr) 1997-09-05
HK1017999A1 (en) 1999-12-10
EP0906101A1 (fr) 1999-04-07
IN187739B (hu) 2002-06-15
SK282112B6 (sk) 2001-11-06
PL328763A1 (en) 1999-02-15
KR100369888B1 (ko) 2003-05-17
CO4780020A1 (es) 1999-05-26
CZ279198A3 (cs) 1999-01-13
DE69713505D1 (de) 2002-07-25
JP2000512617A (ja) 2000-09-26
IL126050A0 (en) 1999-05-09
SK121098A3 (en) 1999-01-11
BR9707827A (pt) 1999-07-27
ZA971830B (en) 1997-09-04
RU2173997C2 (ru) 2001-09-27

Similar Documents

Publication Publication Date Title
HUP0002196A2 (hu) Gyógyhatású táplálékkiegészítő cukorbetegek részére
HUP0002935A2 (hu) Gyomorban visszatartott, szabályozott hatóanyag kibocsátású mikrogömböcskék javított gyógyszeradagolás elősegítésére
PT797991E (pt) Formulacao com libertacao prolongada contendo venlafaxina
CA2186039A1 (en) New oral pharmaceutical dosage form
ATE211907T1 (de) Osmotisches arzneimittelfreisetzungssystem
AU678859C (en) Immediate release tablet cores of insoluble drugs having sustained release coating
NO996433L (no) Nye formuleringer av legemidler, fremgangsmåter for fremstilling derav og fremgangsmåter for anvendelse derav
DZ2685A1 (fr) Formulation pharmaceutique orale à libération prolongée.
BR0109943A (pt) Composições farmacêuticas
ZA986043B (en) Skin care compositions containing an organic extract of chick pea.
HUP9904065A2 (hu) Olanzapint tartalmazó bevonatos gyógyszerkészítmények
NO305903B1 (no) Benzonitriler og benzofluorider, legemidler bestående av forbindelsene, farmasöytiske preparater inneholdende forbindelsene, samt anvendelse av forbindelsene for fremstilling av farmasöytiske preparater
SE9700885D0 (sv) New pharmaceutical formulation
MY115433A (en) Film coated tablet of paracetamol and domperidone.
HUP0104647A2 (hu) Hatóanyagként tilidin-mezilátot tartalmazó, szabályozott hatóanyag-leadású gyógyszerkészítmény
HUP9902458A2 (hu) Nyújtott hatóanyag-leadású, mizolasztintartalmú gyógyszerkészítmények
CO5011082A1 (es) Formulacion medicamentosa con liberacion controlada de sus- tancia activa
NO995831D0 (no) Injiserbar, klar formulering av et anestetisk middel
RS50298B (sr) Direktno kompresibilna matrica za kontrolisano oslobađanje pojedinačnih dnevnih doza klaritromicina
HUP9800573A2 (hu) Orálisan beadható rapamicintartalmú készítmények és eljárás előállításukra
NO306060B1 (no) Substituerte kanelsyreguanidider, deres anvendelse samt medikamenter inneholdende guanididene
DE69108143T2 (de) Rotogranulate und geschmacksabdeckende Überzüge zur Herstellung pharmazeutischer Kautabletten.
HUP0003341A2 (hu) Orális adagolásra alkalmas rapamicinkészítmények
AU7296696A (en) Deodorising formulations containing cationic biopolymers, aluminium chlorhydrate and esterase inhibitors
HUP0202324A2 (hu) Prukaloprid orális oldat